08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
Where does creativity fit into compliance? In more places than you think. Problem-solving, accountab...
Read More >
The State of California has filed a notice of appeal of the district court’s decision granting a pr...
Read More >
On September 26, 2019, California’s Second District Court of Appeals in Gustavo Naranjo, et al. v. ...
Read More >
Quick Hit: On June 28, 2019 The Office of Management and Budget (“OMB”) published notice that “OF...
Read More >
In Conway Construction Company v. City of Puyallup, No. 80649-1-1 (May 4, 2020), the Washington Cour...
Read More >
During the 2019 legislative session, the Maryland General Assembly passed a new bill called “Crimin...
Read More >